ASPIRA PATHLAB & DIAGNOSTICS | NARAYANA HRUDAYALAYA | ASPIRA PATHLAB & DIAGNOSTICS / NARAYANA HRUDAYALAYA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.4 | 33.8 | - | View Chart |
P/BV | x | 2.6 | 12.2 | 20.8% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
ASPIRA PATHLAB & DIAGNOSTICS NARAYANA HRUDAYALAYA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
NARAYANA HRUDAYALAYA Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / NARAYANA HRUDAYALAYA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 816 | 9.2% | |
Low | Rs | 26 | 590 | 4.3% | |
Sales per share (Unadj.) | Rs | 14.0 | 221.4 | 6.3% | |
Earnings per share (Unadj.) | Rs | -0.1 | 29.7 | -0.3% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 40.0 | 3.6% | |
Dividends per share (Unadj.) | Rs | 0 | 2.50 | 0.0% | |
Avg Dividend yield | % | 0 | 0.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 12.4 | 104.3 | 11.9% | |
Shares outstanding (eoy) | m | 10.29 | 204.36 | 5.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 3.2 | 112.8% | |
Avg P/E ratio | x | -583.7 | 23.7 | -2,464.1% | |
P/CF ratio (eoy) | x | 34.6 | 17.6 | 196.7% | |
Price / Book Value ratio | x | 4.1 | 6.7 | 60.2% | |
Dividend payout | % | 0 | 8.4 | -0.0% | |
Avg Mkt Cap | Rs m | 518 | 143,676 | 0.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 8,792 | 0.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 45,248 | 0.3% | |
Other income | Rs m | 3 | 654 | 0.5% | |
Total revenues | Rs m | 148 | 45,902 | 0.3% | |
Gross profit | Rs m | 16 | 9,803 | 0.2% | |
Depreciation | Rs m | 16 | 2,100 | 0.8% | |
Interest | Rs m | 4 | 841 | 0.5% | |
Profit before tax | Rs m | -1 | 7,516 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 1,450 | 0.0% | |
Profit after tax | Rs m | -1 | 6,066 | -0.0% | |
Gross profit margin | % | 11.0 | 21.7 | 50.9% | |
Effective tax rate | % | 0 | 19.3 | -0.0% | |
Net profit margin | % | -0.6 | 13.4 | -4.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 12,947 | 0.5% | |
Current liabilities | Rs m | 16 | 9,880 | 0.2% | |
Net working cap to sales | % | 29.5 | 6.8 | 436.0% | |
Current ratio | x | 3.7 | 1.3 | 282.0% | |
Inventory Days | Days | 88 | 42 | 209.9% | |
Debtors Days | Days | 590 | 35 | 1,696.1% | |
Net fixed assets | Rs m | 115 | 28,626 | 0.4% | |
Share capital | Rs m | 103 | 2,044 | 5.0% | |
"Free" reserves | Rs m | 25 | 19,262 | 0.1% | |
Net worth | Rs m | 128 | 21,306 | 0.6% | |
Long term debt | Rs m | 10 | 6,264 | 0.2% | |
Total assets | Rs m | 173 | 41,573 | 0.4% | |
Interest coverage | x | 0.8 | 9.9 | 7.9% | |
Debt to equity ratio | x | 0.1 | 0.3 | 25.7% | |
Sales to assets ratio | x | 0.8 | 1.1 | 76.6% | |
Return on assets | % | 1.9 | 16.6 | 11.4% | |
Return on equity | % | -0.7 | 28.5 | -2.4% | |
Return on capital | % | 2.4 | 30.3 | 7.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 1,895 | 0.0% | |
Fx outflow | Rs m | 0 | 419 | 0.0% | |
Net fx | Rs m | 0 | 1,476 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 10,846 | -0.0% | |
From Investments | Rs m | 2 | -11,741 | -0.0% | |
From Financial Activity | Rs m | -9 | 877 | -1.1% | |
Net Cashflow | Rs m | -8 | -39 | 20.0% |
Indian Promoters | % | 18.7 | 63.9 | 29.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 20.4 | - | |
FIIs | % | 0.0 | 10.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 36.2 | 224.8% | |
Shareholders | 1,512 | 138,052 | 1.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS VIJAYA DIAGNOSTIC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | NARAYANA HRUDAYALAYA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.14% | 1.02% | 0.45% |
1-Month | -8.93% | 2.05% | 2.55% |
1-Year | -3.33% | 69.18% | 56.14% |
3-Year CAGR | 1.86% | 47.49% | 15.22% |
5-Year CAGR | -1.91% | 43.69% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the NARAYANA HRUDAYALAYA share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of NARAYANA HRUDAYALAYA the stake stands at 63.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of NARAYANA HRUDAYALAYA.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
NARAYANA HRUDAYALAYA paid Rs 2.5, and its dividend payout ratio stood at 8.4%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of NARAYANA HRUDAYALAYA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.